Literature DB >> 21520912

Active-site-directed chemical tools for profiling mitochondrial Lon protease.

Jennifer Fishovitz1, Min Li, Hilary Frase, Jason Hudak, Sandra Craig, Kristin Ko, Anthony J Berdis, Carolyn K Suzuki, Irene Lee.   

Abstract

Lon and ClpXP are the only soluble ATP-dependent proteases within the mammalian mitochondria matrix, which function in protein quality control by selectively degrading misfolded, misassembled, or damaged proteins. Chemical tools to study these proteases in biological samples have not been identified, thereby hindering a clear understanding of their respective functions in normal and disease states. In this study, we applied a proteolytic site-directed approach to identify a peptide reporter substrate and a peptide inhibitor that are selective for Lon but not ClpXP. These chemical tools permit quantitative measurements that distinguish Lon-mediated proteolysis from that of ClpXP in biochemical assays with purified proteases, as well as in intact mitochondria and mitochondrial lysates. This chemical biology approach provides needed tools to further our understanding of mitochondrial ATP-dependent proteolysis and contributes to the future development of diagnostic and pharmacological agents for treating diseases associated with defects in mitochondrial protein quality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21520912      PMCID: PMC3158820          DOI: 10.1021/cb100408w

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  33 in total

1.  A mitochondrial specific stress response in mammalian cells.

Authors:  Quan Zhao; Jianghui Wang; Ilya V Levichkin; Stan Stasinopoulos; Michael T Ryan; Nicholas J Hoogenraad
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  Adenosine triphosphate-dependent degradation of a fluorescent lambda N substrate mimic by Lon protease.

Authors:  I Lee; A J Berdis
Journal:  Anal Biochem       Date:  2001-04-01       Impact factor: 3.365

3.  Ceftriaxone-resistant salmonella infection acquired by a child from cattle.

Authors:  P D Fey; T J Safranek; M E Rupp; E F Dunne; E Ribot; P C Iwen; P A Bradford; F J Angulo; S H Hinrichs
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

4.  Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress.

Authors:  Daniela A Bota; Holly Van Remmen; Kelvin J A Davies
Journal:  FEBS Lett       Date:  2002-12-04       Impact factor: 4.124

5.  Human and mouse mitochondrial orthologs of bacterial ClpX.

Authors:  T J Corydon; M Wilsbech; C Jespersgaard; B S Andresen; A D Borglum; S Pedersen; L Bolund; N Gregersen; P Bross
Journal:  Mamm Genome       Date:  2000-10       Impact factor: 2.957

6.  Functional proteolytic complexes of the human mitochondrial ATP-dependent protease, hClpXP.

Authors:  Sung Gyun Kang; Joaquin Ortega; Satyendra K Singh; Nan Wang; Ning-Na Huang; Alasdair C Steven; Michael R Maurizi
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

7.  Degradation in vitro of bacteriophage lambda N protein by Lon protease from Escherichia coli.

Authors:  M R Maurizi
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

8.  Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism.

Authors:  Daniela A Bota; Kelvin J A Davies
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

9.  The impact of oxidative stress on Arabidopsis mitochondria.

Authors:  L J Sweetlove; J L Heazlewood; V Herald; R Holtzapffel; D A Day; C J Leaver; A H Millar
Journal:  Plant J       Date:  2002-12       Impact factor: 6.417

10.  Transmission of cell stress from endoplasmic reticulum to mitochondria: enhanced expression of Lon protease.

Authors:  Osamu Hori; Fusae Ichinoda; Takashi Tamatani; Atsushi Yamaguchi; Naoya Sato; Kentaro Ozawa; Yasuko Kitao; Mayuki Miyazaki; Heather P Harding; David Ron; Masaya Tohyama; David M Stern; Satoshi Ogawa
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

View more
  7 in total

1.  Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.

Authors:  E Mazzio; K F A Soliman
Journal:  Neurotoxicology       Date:  2012-07-07       Impact factor: 4.294

2.  Release of skeletal muscle peptide fragments identifies individual proteins degraded during insulin deprivation in type 1 diabetic humans and mice.

Authors:  Matthew M Robinson; Surendra Dasari; Helen Karakelides; H Robert Bergen; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

Review 3.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

Review 4.  Multitasking in the mitochondrion by the ATP-dependent Lon protease.

Authors:  Sundararajan Venkatesh; Jae Lee; Kamalendra Singh; Irene Lee; Carolyn K Suzuki
Journal:  Biochim Biophys Acta       Date:  2011-11-18

5.  CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease.

Authors:  Kevin A Strauss; Robert N Jinks; Erik G Puffenberger; Sundararajan Venkatesh; Kamalendra Singh; Iteen Cheng; Natalie Mikita; Jayapalraja Thilagavathi; Jae Lee; Stefan Sarafianos; Abigail Benkert; Alanna Koehler; Anni Zhu; Victoria Trovillion; Madeleine McGlincy; Thierry Morlet; Matthew Deardorff; A Micheil Innes; Chitra Prasad; Albert E Chudley; Irene Nga Wing Lee; Carolyn K Suzuki
Journal:  Am J Hum Genet       Date:  2015-01-08       Impact factor: 11.025

6.  Oxidative damage and impairment of protein quality control systems in keratinocytes exposed to a volatile organic compounds cocktail.

Authors:  Marlène Dezest; Mickael Le Bechec; Laurent Chavatte; Valérie Desauziers; Benoît Chaput; Jean-Louis Grolleau; Pascal Descargues; Carine Nizard; Sylvianne Schnebert; Sylvie Lacombe; Anne-Laure Bulteau
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

7.  Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi.

Authors:  Vilmos Csizmadia; Paul Hales; Christopher Tsu; Jingya Ma; Jiejin Chen; Pooja Shah; Paul Fleming; Joseph J Senn; Vivek J Kadambi; Larry Dick; Francis S Wolenski
Journal:  Toxicol Res (Camb)       Date:  2016-08-25       Impact factor: 3.524

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.